Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: A pilot study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 11, 2007, Pages 1673-1680

  Arevalo, J Fernando ^a,e   Sanchez, Juan G ^a   Garcia, Reinaldo A ^a   Wu, Lihteh ^b   Berrocal, Maria H ^c   Rodriguez, Francisco J ^d   Rodríguez, Alvaro ^d   Novoa, Liliana Andrea ^d   Garcia Amaris, Rafael ^a  

^a Clinica Oftalmologica Centro Caracas   (Venezuela)

^b Instituto de Cirugia Ocular   (Costa Rica)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

^e Clinica Oftalmologica Centro   (Venezuela)

Author keywords

Group 2A; Idiopathic parafoveal telangiectasis; IMP; Indocyanine green; Intravi trealtriamcinolone; Macular edema; Photothrombosis

Indexed keywords

ANTIGLAUCOMA AGENT; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IDIOPATHIC PARAFOVEAL TELANGIECTASIS GROUP 2A; INDOCYANINE GREEN MEDIATED PHOTOTHROMBOSIS; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LOW LEVEL LASER THERAPY; MALE; MEDICAL RECORD; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; SAFETY; SUBRETINAL NEOVASCULARIZATION; TELANGIECTASIA; VISUAL ACUITY;

AGED; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INDOCYANINE GREEN; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PILOT PROJECTS; RETINAL DISEASES; TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 34848823140     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0633-2     Document Type: Article

References (31)

1. Gass JDM, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100:1536-1546
2. Gupta V, Gupta A, Dogra MR, Agarwal A (2005) Optical coherence tomography in group 2A idiopathic juxtafoveolar telangiectasis. Ophthalmic Surg Lasers Imaging 36:482-486
3. Costa RA, Farah ME, Freymüller E, Morales PH, Smith R, Cardillo JA (2001) Choriocapillaris photodynamic therapy using indocyanine green. Am J Ophthalmol 132:557-565
4. Costa RA, Farah ME, Cardillo JA, Belfort R Jr (2001) Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration. Curr Eye Res 23:271-275
5. Costa RA, Meirelles RL, Cardillo JA, Abrantes ML, Farah ME (2003) Retinal capillary hemangioma treatment by indocyanine green-mediated photothrombosis. Am J Ophthalmol 135:395-398
6. Costa RA, Scapucin L, Moraes NS, Calucci D, Melo LA Jr, Cardillo JA, Farah ME (2002) Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 25:287-297
7. Li KW, Goh TY, Parsons H, Chan WM, Lam DS (2005) Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis. Clin Experiment Ophthalmol 33:541-552
8. Alldredge CD, Garretson BR (2003) Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 23:113-116
9. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis. Clin Experiment Ophthalmol 29:2-6
10. Gillies MC, Simpson JM, Luo W et al (2003) A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: One-year results. Arch Ophthalmol 121:667-673
11. Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF (2004) Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 122:218-222
12. Martidis A, Duker JS, Greenberg PB et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927
13. Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A (2005) Intravitreal triamcinolone acetonide for diabetic macular edema. Retina 25:828-834
14. Conway MD, Canakis C, Livir-Rallatos C et al (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29:27-33
15. Park CH, Jaffe GJ, Fekrat S (2003) Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136:419-425
16. Navajas EV, Costa RA, Farah ME, Cardillo JA, Bonomo PP (2003) Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis. Eye 17:563-566
17. Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110:1517-1525
18. Arevalo JF, Garcia RA, Mendoza AJ (2005) Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 243:1180-1185
19. Arevalo JF, Mendoza AJ, Fernandez C (2005) Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: A pilot study. Retina 25:719-726
20. Watzke RC, Klein ML, Folk JC, Farmer SG, Munsen RS, Champfer RJ, Sletten KR (2005) Long-term juxtafoveal retinal telangiectasia. Retina 25:727-735
21. Yannuzzi LA, Bardal AMC, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124:450-460
22. Park DW, Schatz H, McDonald HR, Johnson RN (1997) Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 104:1838-1846
23. De Lahitte GD, Cohen SY, Gaudric A (2004) Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization. Am J Ophthalmol 138:892-894
24. Baumler W, Abels C, Karrer S, Weib T, Messmann H, Landthaler M, Szeimies R-M (1990) Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 80:360-363
25. Peyman GA, Moshfeghi DM (2004) Intravitreal triamcinolone acetonide. Retina 24:488-490
26. Penfold PL, Wen L, Madigan MC, King NJ, Provis JM (2002) Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci 43:3125-3130
27. Wilson CA, Berkowitz BA, Sato Y et al (1992) Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110:1155-1159
28. Ciulla TA, Walker JD, Fong DS, Criswell MH (2004) Corticosteroids in posterior segment disease: An update on new delivery systems and new indications. Curr Opin Ophthal 15:211-220
29. Rhee DJ, Peck RE, Belmont J, Martidis A, Liu M, Chang J, Fontanarosa J, Moster MR (2006) Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol 90:934-935
30. Thompson JT (2006) Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol 141:629-637
31. Jones R, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature. Curr Opin Ophthalmol 17:163-167